Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
Kalambokis
Georgios N
GN
Tsianos
Epameinondas V
EV
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology; D006530:Hepatorenal Syndrome; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy*; D008236:Lypressin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008879:Midodrine / Q000627:therapeutic use; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000316:Adrenergic alpha-Agonists; D014662:Vasoconstrictor Agents; D008236:Lypressin; D008879:Midodrine; D000077585:Terlipressin